Huang M, O'Shaughnessy J, Haiderali A, Pan W, et al. Q-TWiST analysis of pembrolizumab combined with chemotherapy as first-line treatment of metastatic triple-negative breast cancer that expresses PD-L1. Eur J Cancer 2022;177:45-52.
PMID: 36323052